MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 29 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.00800-07v1
28/1/511    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefloch, R.
Right arrow Articles by Lenormand, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefloch, R.
Right arrow Articles by Lenormand, P.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.00800-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Single and combined ERK1/ERK2 silencing reveals their positive contribution to growth signaling depending on their expression levels

Renaud Lefloch, Jacques Pouysségur, and Philippe Lenormand*

Institute of Signaling Developmental Biology and Cancer, CNRS UMR 6543, Université de Nice Sophia Antipolis, Centre A. Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France

* To whom correspondence should be addressed. Email: lenorman{at}unice.fr.


   Abstract

The proteins ERK1 and ERK2 are highly similar, ubiquitously expressed and share activators and substrates; however erk2 gene invalidation is lethal in mice while erk1 is not. We ablated ERK1 and/or ERK2 by RNA interference and explored their relative role in cell proliferation and immediate-early genes (IEGs) expression. Reducing expression of either ERK1 or ERK2 lowered IEG induction by serum, however silencing of only ERK2 slowed-down cell proliferation. When both isoforms were silenced simultaneously, compensating activation of the residual pool of ERK1/2 masked a more deleterious effect on cell proliferation. It is only when ERK2 activation was clamped at a limiting level that we demonstrated the positive contribution of ERK1 to cell proliferation. We then established that ERK isoforms are activated indiscriminately, their expression ratio correlated exactly with their activation ratio. Furthermore, we determined for the first time that ERK1 and ERK2 kinase activities are indistinguishable in vitro and that erk gene dosage is essential for survival of mice. We propose that the expression levels of ERK1 and ERK2 drive their apparent biological differences. Indeed, ERK1 is dispensable in some vertebrates since it is absent from chicken and frog genome despite being present in all fishes sequenced so far.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.